Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection

The use of antiretroviral medications in HIV-negative individuals as pre-exposure prophylaxis (PrEP) is a promising approach to prevent HIV infection. Tenofovir disoproxil fumarate (TDF) and emtricitabine exhibit desirable properties for PrEP including: favourable pharmacokinetics that support infre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of antimicrobial chemotherapy 2011-02, Vol.66 (2), p.240-250
Hauptverfasser:	ANDERSON, Peter L, KISER, Jennifer J, GARDNER, Edward M, ROWER, Joseph E, MEDITZ, Amie, GRANT, Robert M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenine - analogs & derivatives Adenine - pharmacology Adenine - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral drugs Biological and medical sciences Chemoprevention Clinical trials Deoxycytidine - analogs & derivatives Deoxycytidine - pharmacology Deoxycytidine - therapeutic use Disease prevention Drug dosages Drug Interactions Drug therapy Emtricitabine Female Food-Drug Interactions Genetics HIV HIV Infections - drug therapy HIV Infections - prevention & control Human immunodeficiency virus Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Male Medical sciences Organophosphonates - pharmacology Organophosphonates - therapeutic use Pharmacology Pharmacology. Drug treatments Review Tenofovir Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!